Written by Bill Godshall Wednesday, 14 December 2011 17:51
Institute of Medicine urges FDA to protect deadly cigarettes from market competition by far less hazardous smokefree tobacco alternatives.
The new Institute of Medicine (IOM) committee report on Modified Risk Tobacco Products is terrible for public health because it urges the FDA to protect deadly cigarettes from market competition by far less hazardous smokefree alternatives.
The IOM committee is basically urging the FDA to impose a several hundred million dollar tax on any tobacco company before it could truthfully inform smokers that a smokeless tobacco product is less hazardous than cigarettes.
While the report correctly points out that NRT products pose virtually no health risks, it ignores a half century a evidence documenting that smokeless tobacco products in Sweden and the US have very similar health risks/benefit profiles as NRT products.
The IOM committee report also ignores the undeniable evidence that several million smokers in the US and Sweden have already switched to smokeless tobacco products, and have significantly reduced their disease risks by doing so.
The IOM committee's recommendation would require a tobacco company to conduct far more research than FDA requires drug companies to conduct on NRT products before they can be marketed as smoking cessation aids.
Smokers have a human right to truthful health information about far less hazardous alternatives to cigarettes. But this IOM committee obviously disagrees.
In sum, the IOM committee's report protects cigarettes at the expense of public health, human rights and the truth.
Bill GodshallExecutive Director
Smokefree Pennsylvania
1926 Monongahela Avenue
Pittsburgh, PA 15218

Add this page to your favorite Social Bookmarking websites
| Next > |
|---|
2 Comments
FeedAdd Comment
The Latest News from SnusCENTRAL
-
Philip Morris, Swedish Snus, and the Parliament brand in Russia Parliament has been a popular cigarette in Russia since the late 1990s....
-
Parliament Swedish Snus is Here...sort of According to SnusCIA sources, Parliament Snus from Philip Morris International...
-
New V2 Tobacco snus factory starts production V2 Tobacco, Denmark's largest snus manufacturer, announced their new...
-
New General Snus, Catch Snus, and Goteborgs Rapé Snus for 2012 Swedish Match today announced the the upcoming release of new General...
-
Thunder Chrome Series Snus Discontinued Goodbye Thunder Chrome but Coffee Supreme will return V2 Tobacco...
-
New Camel SNUS Ads: Let it Snus, FDA! Reynolds American launch a new series of Camel SNUS print ads today...
-
Bill Godshall - Institute of Medicine report to FDA on Smokeless Tobacco an Outrage Institute of Medicine urges FDA to protect deadly cigarettes from...
-
Save Our Snus! FDA Comment Period Extended FDA has extended the time for public comment on the sale and advertising...
-
Swedish Match Snus News from October 2011 Swedish Match, the world's largest manufacturer of Swedish snus, was...
-
The Nanny States of America, Part 3 When I first started writing for SnusCentral I was under the understanding...
-
Snus News and Snus Lord Moe Unz is back! As I always say after I am cut off at the local pub, "I shall return!"...
-
Going Extreme: Odens EXTREME Snus by GNT Odens Extreme Swedish Snus series was the first snus to break the...
-
Beyond Extra Strong: Thunder RAW Frosted Ultra Strong Snus V2 Tobacco publicly announced they are launching their highest nicotine...
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10






Larry Waters makes this comment
Wednesday, 14 December 2011
Editors Note: The extra line of text added to the IOM Logo was an editorial comment to help clarify the Organization of Medicine for those not familiar with it. Bill Godshall had nothing to do with it.
Song makes this comment
Saturday, 17 December 2011
Its quite funny how doctors whos oath is to save people anyway they can, get all corrupted by big tobacco and will sell out the people health for money from big tobacco and big pharma. These so called "doctors" should all lose there jobs, medical and research licenses.